Evidence map›Paper›PMID 37368240›Full record

ArticleThe Journal of experimental medicine2023

Memory B cell development elicited by mRNA booster vaccinations in the elderly.

Zijun Wang, Frauke Muecksch, Raphael Raspe, Frederik Johannsen, Martina Turroja, Marie Canis, Mohamed A ElTanbouly, Gabriela S Silva Santos, Brianna Johnson, Viren A Baharani and 11 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Memory B cell development in response to mRNA SARS-CoV-2 and nanoparticle immunization in mice.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Zijun WangLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-2095-2151
Frauke MueckschLaboratory of Retrovirology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-0132-5101
Raphael RaspeLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0003-3409-4968
Frederik JohannsenLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0003-1273-8785
Martina TurrojaLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0001-9640-0559
Marie CanisLaboratory of Retrovirology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-9243-867X
Mohamed A ElTanboulyLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0001-7985-3839
Gabriela S Silva SantosLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-7482-7380
Brianna JohnsonLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0003-3214-284X
Viren A BaharaniLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0009-0009-2011-9547
Rachel PatejakLaboratory of Retrovirology, The Rockefeller University , New York, NY, USA.ORCID 0009-0006-2739-9228
Kai-Hui YaoLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0001-7912-5516
Bennett J ChircoLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0009-0006-2068-574X
Katrina G MillardLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0003-2247-3178
Irina ShimeliovichLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-7030-294X
Anna GazumyanLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-5976-9717
Thiago Y OliveiraLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-2654-0879
Paul D BieniaszLaboratory of Retrovirology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-2368-3719
Theodora HatziioannouLaboratory of Retrovirology, The Rockefeller University , New York, NY, USA.ORCID 0000-0002-7889-0766
Marina CaskeyLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0003-1727-8693
Michel C NussenzweigLaboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.ORCID 0000-0003-0592-8564
Rockefeller University · USHoward Hughes Medical Institute · USHeidelberg University · DE

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Understanding B cell memory in response to diverse virus infectionsU19AI111825 · NIAID · ROCKEFELLER UNIVERSITY · PI RAVETCH, JEFFREY VICTOR · 2014 to 2023
$26.0M
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responsesP01AI165075 · NIAID · ROCKEFELLER UNIVERSITY · PI BIENIASZ, PAUL D., BJORKMAN, PAMELA J · 2022 to 2023
$10.7M
Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS.R01AI078788 · NIAID · ROCKEFELLER UNIVERSITY · PI HATZIIOANNOU, THEODORA · 2008 to 2021
$9.3M
Discovery and Mechanism of Antiretroviral FactorsR37AI064003 · NIAID · ROCKEFELLER UNIVERSITY · PI BIENIASZ, PAUL D. · 2011 to 2020
$4.9M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001866NIAID NIH HHS P01 AI165075NIAID NIH HHS R01 AI078788NIAID NIH HHS R37 AI064003NIAID NIH HHS U19 AI111825
6 · The paper itself

Abstract

Despite mRNA vaccination, elderly individuals remain especially vulnerable to severe consequences of SARS-CoV-2 infection. Here, we compare the memory B cell responses in a cohort of elderly and younger individuals who received mRNA booster vaccinations. Plasma neutralizing potency and breadth were similar between the two groups. By contrast, the absolute number of SARS-CoV-2-specific memory B cells was lower in the elderly. Antibody sequencing revealed that the SARS-CoV-2-specific elderly memory compartments were more clonal and less diverse. Notably, memory antibodies from the elderly preferentially targeted the ACE2-binding site on the RBD, while those from younger individuals targeted less accessible but more conserved epitopes. Nevertheless, individual memory antibodies elicited by booster vaccines in the elderly and younger individuals showed similar levels of neutralizing activity and breadth against SARS-CoV-2 variants. Thus, the relatively diminished protective effects of vaccination against serious disease in the elderly are associated with a smaller number of antigen-specific memory B cells that express altered antibody repertoires.

Indexed as

COVID-19Memory B CellsAgedAntibodiesAntibodies, NeutralizingAntibodies, ViralHumansRNA, MessengerSARS-CoV-2VaccinationAntibodiesAntibodies, NeutralizingAntibodies, ViralRNA, Messenger

Identifiers

PMID37368240
PMCPMC10300432
OpenAlexW4382182059

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.